Global Biodefense Market 2024 by Company, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Biodefense market size was valued at USD 1177.1 million in 2023 and is forecast to a readjusted size of USD 1888.5 million by 2030 with a CAGR of 7.0% during review period.
Biodefense market refers to the pharmaceuticals, vaccines and antibodies applied in the treatment of a wide range of infectious diseases, whether those diseases emerge naturally or are deliberately introduced as an act of bioterrorism. Biodefense products generally defense against anthrax, smallpox, botulism, radiation/nuclear disasters and other disasters.
In the wake of the 2001 anthrax attacks, the U.S. government set out on a bold path to improve the country’s preparedness for bioterrorism by developing and stockpiling new drugs and vaccines to protect Americans from health emergencies. Since 2004, the US government has provided assistance in the development and manufacturing of products in order to maintain its Strategic National Stockpile (SNS) to counter any bioterror attack.
The major players in global Biodefense market include Emergent Biosolutions, Hytest, GSK, etc. The top 3 players occupy about 60% shares of the global market. North America, Europe and Asia are key Regions of Sales. Anthrax and Smallpox are main types, with a share about 70%. US Civilian Market is the main application, which holds a share about 55%.
The Global Info Research report includes an overview of the development of the Biodefense industry chain, the market status of US Military Market (Anthrax, Smallpox), US Civilian Market (Anthrax, Smallpox), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Biodefense.
Regionally, the report analyzes the Biodefense markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Biodefense market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Biodefense market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Biodefense industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Anthrax, Smallpox).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Biodefense market.
Regional Analysis: The report involves examining the Biodefense market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Biodefense market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Biodefense:
Company Analysis: Report covers individual Biodefense players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Biodefense This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (US Military Market, US Civilian Market).
Technology Analysis: Report covers specific technologies relevant to Biodefense. It assesses the current state, advancements, and potential future developments in Biodefense areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Biodefense market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Biodefense market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Chapter 1, to describe Biodefense product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Biodefense, with revenue, gross margin and global market share of Biodefense from 2019 to 2024.
Chapter 3, the Biodefense competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Biodefense market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Biodefense.
Chapter 13, to describe Biodefense research findings and conclusion.
Biodefense market refers to the pharmaceuticals, vaccines and antibodies applied in the treatment of a wide range of infectious diseases, whether those diseases emerge naturally or are deliberately introduced as an act of bioterrorism. Biodefense products generally defense against anthrax, smallpox, botulism, radiation/nuclear disasters and other disasters.
In the wake of the 2001 anthrax attacks, the U.S. government set out on a bold path to improve the country’s preparedness for bioterrorism by developing and stockpiling new drugs and vaccines to protect Americans from health emergencies. Since 2004, the US government has provided assistance in the development and manufacturing of products in order to maintain its Strategic National Stockpile (SNS) to counter any bioterror attack.
The major players in global Biodefense market include Emergent Biosolutions, Hytest, GSK, etc. The top 3 players occupy about 60% shares of the global market. North America, Europe and Asia are key Regions of Sales. Anthrax and Smallpox are main types, with a share about 70%. US Civilian Market is the main application, which holds a share about 55%.
The Global Info Research report includes an overview of the development of the Biodefense industry chain, the market status of US Military Market (Anthrax, Smallpox), US Civilian Market (Anthrax, Smallpox), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Biodefense.
Regionally, the report analyzes the Biodefense markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Biodefense market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Biodefense market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Biodefense industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Anthrax, Smallpox).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Biodefense market.
Regional Analysis: The report involves examining the Biodefense market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Biodefense market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Biodefense:
Company Analysis: Report covers individual Biodefense players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Biodefense This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (US Military Market, US Civilian Market).
Technology Analysis: Report covers specific technologies relevant to Biodefense. It assesses the current state, advancements, and potential future developments in Biodefense areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Biodefense market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Biodefense market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
- Anthrax
- Smallpox
- Botulism
- Radiation/Nuclear
- Others
- US Military Market
- US Civilian Market
- Non - US Market
- Emergent Biosolutions
- Hytest
- GSK
- Sanofi
- PharmAthene
- Bavarian Nordic
- SIGA Technologies
- Arbutus Biopharma
- DynPort Vaccine
- Xoma Corporation
- Ichor Medical Systems
- Aeolus Pharmaceuticals
- Achaogen
- Elusys Therapeutics
- Dynavax Technologies
- Cleveland BioLabs
- Soligenix
- Alnylam Pharmaceuticals
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Biodefense product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Biodefense, with revenue, gross margin and global market share of Biodefense from 2019 to 2024.
Chapter 3, the Biodefense competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Biodefense market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Biodefense.
Chapter 13, to describe Biodefense research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Biodefense
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Biodefense by Type
1.3.1 Overview: Global Biodefense Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Biodefense Consumption Value Market Share by Type in 2023
1.3.3 Anthrax
1.3.4 Smallpox
1.3.5 Botulism
1.3.6 Radiation/Nuclear
1.3.7 Others
1.4 Global Biodefense Market by Application
1.4.1 Overview: Global Biodefense Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 US Military Market
1.4.3 US Civilian Market
1.4.4 Non - US Market
1.5 Global Biodefense Market Size & Forecast
1.6 Global Biodefense Market Size and Forecast by Region
1.6.1 Global Biodefense Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Biodefense Market Size by Region, (2019-2030)
1.6.3 North America Biodefense Market Size and Prospect (2019-2030)
1.6.4 Europe Biodefense Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Biodefense Market Size and Prospect (2019-2030)
1.6.6 South America Biodefense Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Biodefense Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Emergent Biosolutions
2.1.1 Emergent Biosolutions Details
2.1.2 Emergent Biosolutions Major Business
2.1.3 Emergent Biosolutions Biodefense Product and Solutions
2.1.4 Emergent Biosolutions Biodefense Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Emergent Biosolutions Recent Developments and Future Plans
2.2 Hytest
2.2.1 Hytest Details
2.2.2 Hytest Major Business
2.2.3 Hytest Biodefense Product and Solutions
2.2.4 Hytest Biodefense Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Hytest Recent Developments and Future Plans
2.3 GSK
2.3.1 GSK Details
2.3.2 GSK Major Business
2.3.3 GSK Biodefense Product and Solutions
2.3.4 GSK Biodefense Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 GSK Recent Developments and Future Plans
2.4 Sanofi
2.4.1 Sanofi Details
2.4.2 Sanofi Major Business
2.4.3 Sanofi Biodefense Product and Solutions
2.4.4 Sanofi Biodefense Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Sanofi Recent Developments and Future Plans
2.5 PharmAthene
2.5.1 PharmAthene Details
2.5.2 PharmAthene Major Business
2.5.3 PharmAthene Biodefense Product and Solutions
2.5.4 PharmAthene Biodefense Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 PharmAthene Recent Developments and Future Plans
2.6 Bavarian Nordic
2.6.1 Bavarian Nordic Details
2.6.2 Bavarian Nordic Major Business
2.6.3 Bavarian Nordic Biodefense Product and Solutions
2.6.4 Bavarian Nordic Biodefense Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Bavarian Nordic Recent Developments and Future Plans
2.7 SIGA Technologies
2.7.1 SIGA Technologies Details
2.7.2 SIGA Technologies Major Business
2.7.3 SIGA Technologies Biodefense Product and Solutions
2.7.4 SIGA Technologies Biodefense Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 SIGA Technologies Recent Developments and Future Plans
2.8 Arbutus Biopharma
2.8.1 Arbutus Biopharma Details
2.8.2 Arbutus Biopharma Major Business
2.8.3 Arbutus Biopharma Biodefense Product and Solutions
2.8.4 Arbutus Biopharma Biodefense Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Arbutus Biopharma Recent Developments and Future Plans
2.9 DynPort Vaccine
2.9.1 DynPort Vaccine Details
2.9.2 DynPort Vaccine Major Business
2.9.3 DynPort Vaccine Biodefense Product and Solutions
2.9.4 DynPort Vaccine Biodefense Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 DynPort Vaccine Recent Developments and Future Plans
2.10 Xoma Corporation
2.10.1 Xoma Corporation Details
2.10.2 Xoma Corporation Major Business
2.10.3 Xoma Corporation Biodefense Product and Solutions
2.10.4 Xoma Corporation Biodefense Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Xoma Corporation Recent Developments and Future Plans
2.11 Ichor Medical Systems
2.11.1 Ichor Medical Systems Details
2.11.2 Ichor Medical Systems Major Business
2.11.3 Ichor Medical Systems Biodefense Product and Solutions
2.11.4 Ichor Medical Systems Biodefense Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Ichor Medical Systems Recent Developments and Future Plans
2.12 Aeolus Pharmaceuticals
2.12.1 Aeolus Pharmaceuticals Details
2.12.2 Aeolus Pharmaceuticals Major Business
2.12.3 Aeolus Pharmaceuticals Biodefense Product and Solutions
2.12.4 Aeolus Pharmaceuticals Biodefense Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Aeolus Pharmaceuticals Recent Developments and Future Plans
2.13 Achaogen
2.13.1 Achaogen Details
2.13.2 Achaogen Major Business
2.13.3 Achaogen Biodefense Product and Solutions
2.13.4 Achaogen Biodefense Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Achaogen Recent Developments and Future Plans
2.14 Elusys Therapeutics
2.14.1 Elusys Therapeutics Details
2.14.2 Elusys Therapeutics Major Business
2.14.3 Elusys Therapeutics Biodefense Product and Solutions
2.14.4 Elusys Therapeutics Biodefense Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Elusys Therapeutics Recent Developments and Future Plans
2.15 Dynavax Technologies
2.15.1 Dynavax Technologies Details
2.15.2 Dynavax Technologies Major Business
2.15.3 Dynavax Technologies Biodefense Product and Solutions
2.15.4 Dynavax Technologies Biodefense Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Dynavax Technologies Recent Developments and Future Plans
2.16 Cleveland BioLabs
2.16.1 Cleveland BioLabs Details
2.16.2 Cleveland BioLabs Major Business
2.16.3 Cleveland BioLabs Biodefense Product and Solutions
2.16.4 Cleveland BioLabs Biodefense Revenue, Gross Margin and Market Share (2019-2024)
2.16.5 Cleveland BioLabs Recent Developments and Future Plans
2.17 Soligenix
2.17.1 Soligenix Details
2.17.2 Soligenix Major Business
2.17.3 Soligenix Biodefense Product and Solutions
2.17.4 Soligenix Biodefense Revenue, Gross Margin and Market Share (2019-2024)
2.17.5 Soligenix Recent Developments and Future Plans
2.18 Alnylam Pharmaceuticals
2.18.1 Alnylam Pharmaceuticals Details
2.18.2 Alnylam Pharmaceuticals Major Business
2.18.3 Alnylam Pharmaceuticals Biodefense Product and Solutions
2.18.4 Alnylam Pharmaceuticals Biodefense Revenue, Gross Margin and Market Share (2019-2024)
2.18.5 Alnylam Pharmaceuticals Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Biodefense Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Biodefense by Company Revenue
3.2.2 Top 3 Biodefense Players Market Share in 2023
3.2.3 Top 6 Biodefense Players Market Share in 2023
3.3 Biodefense Market: Overall Company Footprint Analysis
3.3.1 Biodefense Market: Region Footprint
3.3.2 Biodefense Market: Company Product Type Footprint
3.3.3 Biodefense Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Biodefense Consumption Value and Market Share by Type (2019-2024)
4.2 Global Biodefense Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Biodefense Consumption Value Market Share by Application (2019-2024)
5.2 Global Biodefense Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Biodefense Consumption Value by Type (2019-2030)
6.2 North America Biodefense Consumption Value by Application (2019-2030)
6.3 North America Biodefense Market Size by Country
6.3.1 North America Biodefense Consumption Value by Country (2019-2030)
6.3.2 United States Biodefense Market Size and Forecast (2019-2030)
6.3.3 Canada Biodefense Market Size and Forecast (2019-2030)
6.3.4 Mexico Biodefense Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Biodefense Consumption Value by Type (2019-2030)
7.2 Europe Biodefense Consumption Value by Application (2019-2030)
7.3 Europe Biodefense Market Size by Country
7.3.1 Europe Biodefense Consumption Value by Country (2019-2030)
7.3.2 Germany Biodefense Market Size and Forecast (2019-2030)
7.3.3 France Biodefense Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Biodefense Market Size and Forecast (2019-2030)
7.3.5 Russia Biodefense Market Size and Forecast (2019-2030)
7.3.6 Italy Biodefense Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Biodefense Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Biodefense Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Biodefense Market Size by Region
8.3.1 Asia-Pacific Biodefense Consumption Value by Region (2019-2030)
8.3.2 China Biodefense Market Size and Forecast (2019-2030)
8.3.3 Japan Biodefense Market Size and Forecast (2019-2030)
8.3.4 South Korea Biodefense Market Size and Forecast (2019-2030)
8.3.5 India Biodefense Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Biodefense Market Size and Forecast (2019-2030)
8.3.7 Australia Biodefense Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Biodefense Consumption Value by Type (2019-2030)
9.2 South America Biodefense Consumption Value by Application (2019-2030)
9.3 South America Biodefense Market Size by Country
9.3.1 South America Biodefense Consumption Value by Country (2019-2030)
9.3.2 Brazil Biodefense Market Size and Forecast (2019-2030)
9.3.3 Argentina Biodefense Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Biodefense Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Biodefense Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Biodefense Market Size by Country
10.3.1 Middle East & Africa Biodefense Consumption Value by Country (2019-2030)
10.3.2 Turkey Biodefense Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Biodefense Market Size and Forecast (2019-2030)
10.3.4 UAE Biodefense Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Biodefense Market Drivers
11.2 Biodefense Market Restraints
11.3 Biodefense Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Biodefense Industry Chain
12.2 Biodefense Upstream Analysis
12.3 Biodefense Midstream Analysis
12.4 Biodefense Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Biodefense
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Biodefense by Type
1.3.1 Overview: Global Biodefense Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Biodefense Consumption Value Market Share by Type in 2023
1.3.3 Anthrax
1.3.4 Smallpox
1.3.5 Botulism
1.3.6 Radiation/Nuclear
1.3.7 Others
1.4 Global Biodefense Market by Application
1.4.1 Overview: Global Biodefense Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 US Military Market
1.4.3 US Civilian Market
1.4.4 Non - US Market
1.5 Global Biodefense Market Size & Forecast
1.6 Global Biodefense Market Size and Forecast by Region
1.6.1 Global Biodefense Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Biodefense Market Size by Region, (2019-2030)
1.6.3 North America Biodefense Market Size and Prospect (2019-2030)
1.6.4 Europe Biodefense Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Biodefense Market Size and Prospect (2019-2030)
1.6.6 South America Biodefense Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Biodefense Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Emergent Biosolutions
2.1.1 Emergent Biosolutions Details
2.1.2 Emergent Biosolutions Major Business
2.1.3 Emergent Biosolutions Biodefense Product and Solutions
2.1.4 Emergent Biosolutions Biodefense Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Emergent Biosolutions Recent Developments and Future Plans
2.2 Hytest
2.2.1 Hytest Details
2.2.2 Hytest Major Business
2.2.3 Hytest Biodefense Product and Solutions
2.2.4 Hytest Biodefense Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Hytest Recent Developments and Future Plans
2.3 GSK
2.3.1 GSK Details
2.3.2 GSK Major Business
2.3.3 GSK Biodefense Product and Solutions
2.3.4 GSK Biodefense Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 GSK Recent Developments and Future Plans
2.4 Sanofi
2.4.1 Sanofi Details
2.4.2 Sanofi Major Business
2.4.3 Sanofi Biodefense Product and Solutions
2.4.4 Sanofi Biodefense Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Sanofi Recent Developments and Future Plans
2.5 PharmAthene
2.5.1 PharmAthene Details
2.5.2 PharmAthene Major Business
2.5.3 PharmAthene Biodefense Product and Solutions
2.5.4 PharmAthene Biodefense Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 PharmAthene Recent Developments and Future Plans
2.6 Bavarian Nordic
2.6.1 Bavarian Nordic Details
2.6.2 Bavarian Nordic Major Business
2.6.3 Bavarian Nordic Biodefense Product and Solutions
2.6.4 Bavarian Nordic Biodefense Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Bavarian Nordic Recent Developments and Future Plans
2.7 SIGA Technologies
2.7.1 SIGA Technologies Details
2.7.2 SIGA Technologies Major Business
2.7.3 SIGA Technologies Biodefense Product and Solutions
2.7.4 SIGA Technologies Biodefense Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 SIGA Technologies Recent Developments and Future Plans
2.8 Arbutus Biopharma
2.8.1 Arbutus Biopharma Details
2.8.2 Arbutus Biopharma Major Business
2.8.3 Arbutus Biopharma Biodefense Product and Solutions
2.8.4 Arbutus Biopharma Biodefense Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Arbutus Biopharma Recent Developments and Future Plans
2.9 DynPort Vaccine
2.9.1 DynPort Vaccine Details
2.9.2 DynPort Vaccine Major Business
2.9.3 DynPort Vaccine Biodefense Product and Solutions
2.9.4 DynPort Vaccine Biodefense Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 DynPort Vaccine Recent Developments and Future Plans
2.10 Xoma Corporation
2.10.1 Xoma Corporation Details
2.10.2 Xoma Corporation Major Business
2.10.3 Xoma Corporation Biodefense Product and Solutions
2.10.4 Xoma Corporation Biodefense Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Xoma Corporation Recent Developments and Future Plans
2.11 Ichor Medical Systems
2.11.1 Ichor Medical Systems Details
2.11.2 Ichor Medical Systems Major Business
2.11.3 Ichor Medical Systems Biodefense Product and Solutions
2.11.4 Ichor Medical Systems Biodefense Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Ichor Medical Systems Recent Developments and Future Plans
2.12 Aeolus Pharmaceuticals
2.12.1 Aeolus Pharmaceuticals Details
2.12.2 Aeolus Pharmaceuticals Major Business
2.12.3 Aeolus Pharmaceuticals Biodefense Product and Solutions
2.12.4 Aeolus Pharmaceuticals Biodefense Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Aeolus Pharmaceuticals Recent Developments and Future Plans
2.13 Achaogen
2.13.1 Achaogen Details
2.13.2 Achaogen Major Business
2.13.3 Achaogen Biodefense Product and Solutions
2.13.4 Achaogen Biodefense Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Achaogen Recent Developments and Future Plans
2.14 Elusys Therapeutics
2.14.1 Elusys Therapeutics Details
2.14.2 Elusys Therapeutics Major Business
2.14.3 Elusys Therapeutics Biodefense Product and Solutions
2.14.4 Elusys Therapeutics Biodefense Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Elusys Therapeutics Recent Developments and Future Plans
2.15 Dynavax Technologies
2.15.1 Dynavax Technologies Details
2.15.2 Dynavax Technologies Major Business
2.15.3 Dynavax Technologies Biodefense Product and Solutions
2.15.4 Dynavax Technologies Biodefense Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Dynavax Technologies Recent Developments and Future Plans
2.16 Cleveland BioLabs
2.16.1 Cleveland BioLabs Details
2.16.2 Cleveland BioLabs Major Business
2.16.3 Cleveland BioLabs Biodefense Product and Solutions
2.16.4 Cleveland BioLabs Biodefense Revenue, Gross Margin and Market Share (2019-2024)
2.16.5 Cleveland BioLabs Recent Developments and Future Plans
2.17 Soligenix
2.17.1 Soligenix Details
2.17.2 Soligenix Major Business
2.17.3 Soligenix Biodefense Product and Solutions
2.17.4 Soligenix Biodefense Revenue, Gross Margin and Market Share (2019-2024)
2.17.5 Soligenix Recent Developments and Future Plans
2.18 Alnylam Pharmaceuticals
2.18.1 Alnylam Pharmaceuticals Details
2.18.2 Alnylam Pharmaceuticals Major Business
2.18.3 Alnylam Pharmaceuticals Biodefense Product and Solutions
2.18.4 Alnylam Pharmaceuticals Biodefense Revenue, Gross Margin and Market Share (2019-2024)
2.18.5 Alnylam Pharmaceuticals Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Biodefense Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Biodefense by Company Revenue
3.2.2 Top 3 Biodefense Players Market Share in 2023
3.2.3 Top 6 Biodefense Players Market Share in 2023
3.3 Biodefense Market: Overall Company Footprint Analysis
3.3.1 Biodefense Market: Region Footprint
3.3.2 Biodefense Market: Company Product Type Footprint
3.3.3 Biodefense Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Biodefense Consumption Value and Market Share by Type (2019-2024)
4.2 Global Biodefense Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Biodefense Consumption Value Market Share by Application (2019-2024)
5.2 Global Biodefense Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Biodefense Consumption Value by Type (2019-2030)
6.2 North America Biodefense Consumption Value by Application (2019-2030)
6.3 North America Biodefense Market Size by Country
6.3.1 North America Biodefense Consumption Value by Country (2019-2030)
6.3.2 United States Biodefense Market Size and Forecast (2019-2030)
6.3.3 Canada Biodefense Market Size and Forecast (2019-2030)
6.3.4 Mexico Biodefense Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Biodefense Consumption Value by Type (2019-2030)
7.2 Europe Biodefense Consumption Value by Application (2019-2030)
7.3 Europe Biodefense Market Size by Country
7.3.1 Europe Biodefense Consumption Value by Country (2019-2030)
7.3.2 Germany Biodefense Market Size and Forecast (2019-2030)
7.3.3 France Biodefense Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Biodefense Market Size and Forecast (2019-2030)
7.3.5 Russia Biodefense Market Size and Forecast (2019-2030)
7.3.6 Italy Biodefense Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Biodefense Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Biodefense Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Biodefense Market Size by Region
8.3.1 Asia-Pacific Biodefense Consumption Value by Region (2019-2030)
8.3.2 China Biodefense Market Size and Forecast (2019-2030)
8.3.3 Japan Biodefense Market Size and Forecast (2019-2030)
8.3.4 South Korea Biodefense Market Size and Forecast (2019-2030)
8.3.5 India Biodefense Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Biodefense Market Size and Forecast (2019-2030)
8.3.7 Australia Biodefense Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Biodefense Consumption Value by Type (2019-2030)
9.2 South America Biodefense Consumption Value by Application (2019-2030)
9.3 South America Biodefense Market Size by Country
9.3.1 South America Biodefense Consumption Value by Country (2019-2030)
9.3.2 Brazil Biodefense Market Size and Forecast (2019-2030)
9.3.3 Argentina Biodefense Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Biodefense Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Biodefense Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Biodefense Market Size by Country
10.3.1 Middle East & Africa Biodefense Consumption Value by Country (2019-2030)
10.3.2 Turkey Biodefense Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Biodefense Market Size and Forecast (2019-2030)
10.3.4 UAE Biodefense Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Biodefense Market Drivers
11.2 Biodefense Market Restraints
11.3 Biodefense Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Biodefense Industry Chain
12.2 Biodefense Upstream Analysis
12.3 Biodefense Midstream Analysis
12.4 Biodefense Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Biodefense Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Biodefense Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Biodefense Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Biodefense Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Emergent Biosolutions Company Information, Head Office, and Major Competitors
Table 6. Emergent Biosolutions Major Business
Table 7. Emergent Biosolutions Biodefense Product and Solutions
Table 8. Emergent Biosolutions Biodefense Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Emergent Biosolutions Recent Developments and Future Plans
Table 10. Hytest Company Information, Head Office, and Major Competitors
Table 11. Hytest Major Business
Table 12. Hytest Biodefense Product and Solutions
Table 13. Hytest Biodefense Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Hytest Recent Developments and Future Plans
Table 15. GSK Company Information, Head Office, and Major Competitors
Table 16. GSK Major Business
Table 17. GSK Biodefense Product and Solutions
Table 18. GSK Biodefense Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. GSK Recent Developments and Future Plans
Table 20. Sanofi Company Information, Head Office, and Major Competitors
Table 21. Sanofi Major Business
Table 22. Sanofi Biodefense Product and Solutions
Table 23. Sanofi Biodefense Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Sanofi Recent Developments and Future Plans
Table 25. PharmAthene Company Information, Head Office, and Major Competitors
Table 26. PharmAthene Major Business
Table 27. PharmAthene Biodefense Product and Solutions
Table 28. PharmAthene Biodefense Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. PharmAthene Recent Developments and Future Plans
Table 30. Bavarian Nordic Company Information, Head Office, and Major Competitors
Table 31. Bavarian Nordic Major Business
Table 32. Bavarian Nordic Biodefense Product and Solutions
Table 33. Bavarian Nordic Biodefense Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Bavarian Nordic Recent Developments and Future Plans
Table 35. SIGA Technologies Company Information, Head Office, and Major Competitors
Table 36. SIGA Technologies Major Business
Table 37. SIGA Technologies Biodefense Product and Solutions
Table 38. SIGA Technologies Biodefense Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. SIGA Technologies Recent Developments and Future Plans
Table 40. Arbutus Biopharma Company Information, Head Office, and Major Competitors
Table 41. Arbutus Biopharma Major Business
Table 42. Arbutus Biopharma Biodefense Product and Solutions
Table 43. Arbutus Biopharma Biodefense Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Arbutus Biopharma Recent Developments and Future Plans
Table 45. DynPort Vaccine Company Information, Head Office, and Major Competitors
Table 46. DynPort Vaccine Major Business
Table 47. DynPort Vaccine Biodefense Product and Solutions
Table 48. DynPort Vaccine Biodefense Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. DynPort Vaccine Recent Developments and Future Plans
Table 50. Xoma Corporation Company Information, Head Office, and Major Competitors
Table 51. Xoma Corporation Major Business
Table 52. Xoma Corporation Biodefense Product and Solutions
Table 53. Xoma Corporation Biodefense Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Xoma Corporation Recent Developments and Future Plans
Table 55. Ichor Medical Systems Company Information, Head Office, and Major Competitors
Table 56. Ichor Medical Systems Major Business
Table 57. Ichor Medical Systems Biodefense Product and Solutions
Table 58. Ichor Medical Systems Biodefense Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. Ichor Medical Systems Recent Developments and Future Plans
Table 60. Aeolus Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 61. Aeolus Pharmaceuticals Major Business
Table 62. Aeolus Pharmaceuticals Biodefense Product and Solutions
Table 63. Aeolus Pharmaceuticals Biodefense Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 64. Aeolus Pharmaceuticals Recent Developments and Future Plans
Table 65. Achaogen Company Information, Head Office, and Major Competitors
Table 66. Achaogen Major Business
Table 67. Achaogen Biodefense Product and Solutions
Table 68. Achaogen Biodefense Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 69. Achaogen Recent Developments and Future Plans
Table 70. Elusys Therapeutics Company Information, Head Office, and Major Competitors
Table 71. Elusys Therapeutics Major Business
Table 72. Elusys Therapeutics Biodefense Product and Solutions
Table 73. Elusys Therapeutics Biodefense Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 74. Elusys Therapeutics Recent Developments and Future Plans
Table 75. Dynavax Technologies Company Information, Head Office, and Major Competitors
Table 76. Dynavax Technologies Major Business
Table 77. Dynavax Technologies Biodefense Product and Solutions
Table 78. Dynavax Technologies Biodefense Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 79. Dynavax Technologies Recent Developments and Future Plans
Table 80. Cleveland BioLabs Company Information, Head Office, and Major Competitors
Table 81. Cleveland BioLabs Major Business
Table 82. Cleveland BioLabs Biodefense Product and Solutions
Table 83. Cleveland BioLabs Biodefense Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 84. Cleveland BioLabs Recent Developments and Future Plans
Table 85. Soligenix Company Information, Head Office, and Major Competitors
Table 86. Soligenix Major Business
Table 87. Soligenix Biodefense Product and Solutions
Table 88. Soligenix Biodefense Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. Soligenix Recent Developments and Future Plans
Table 90. Alnylam Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 91. Alnylam Pharmaceuticals Major Business
Table 92. Alnylam Pharmaceuticals Biodefense Product and Solutions
Table 93. Alnylam Pharmaceuticals Biodefense Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 94. Alnylam Pharmaceuticals Recent Developments and Future Plans
Table 95. Global Biodefense Revenue (USD Million) by Players (2019-2024)
Table 96. Global Biodefense Revenue Share by Players (2019-2024)
Table 97. Breakdown of Biodefense by Company Type (Tier 1, Tier 2, and Tier 3)
Table 98. Market Position of Players in Biodefense, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 99. Head Office of Key Biodefense Players
Table 100. Biodefense Market: Company Product Type Footprint
Table 101. Biodefense Market: Company Product Application Footprint
Table 102. Biodefense New Market Entrants and Barriers to Market Entry
Table 103. Biodefense Mergers, Acquisition, Agreements, and Collaborations
Table 104. Global Biodefense Consumption Value (USD Million) by Type (2019-2024)
Table 105. Global Biodefense Consumption Value Share by Type (2019-2024)
Table 106. Global Biodefense Consumption Value Forecast by Type (2025-2030)
Table 107. Global Biodefense Consumption Value by Application (2019-2024)
Table 108. Global Biodefense Consumption Value Forecast by Application (2025-2030)
Table 109. North America Biodefense Consumption Value by Type (2019-2024) & (USD Million)
Table 110. North America Biodefense Consumption Value by Type (2025-2030) & (USD Million)
Table 111. North America Biodefense Consumption Value by Application (2019-2024) & (USD Million)
Table 112. North America Biodefense Consumption Value by Application (2025-2030) & (USD Million)
Table 113. North America Biodefense Consumption Value by Country (2019-2024) & (USD Million)
Table 114. North America Biodefense Consumption Value by Country (2025-2030) & (USD Million)
Table 115. Europe Biodefense Consumption Value by Type (2019-2024) & (USD Million)
Table 116. Europe Biodefense Consumption Value by Type (2025-2030) & (USD Million)
Table 117. Europe Biodefense Consumption Value by Application (2019-2024) & (USD Million)
Table 118. Europe Biodefense Consumption Value by Application (2025-2030) & (USD Million)
Table 119. Europe Biodefense Consumption Value by Country (2019-2024) & (USD Million)
Table 120. Europe Biodefense Consumption Value by Country (2025-2030) & (USD Million)
Table 121. Asia-Pacific Biodefense Consumption Value by Type (2019-2024) & (USD Million)
Table 122. Asia-Pacific Biodefense Consumption Value by Type (2025-2030) & (USD Million)
Table 123. Asia-Pacific Biodefense Consumption Value by Application (2019-2024) & (USD Million)
Table 124. Asia-Pacific Biodefense Consumption Value by Application (2025-2030) & (USD Million)
Table 125. Asia-Pacific Biodefense Consumption Value by Region (2019-2024) & (USD Million)
Table 126. Asia-Pacific Biodefense Consumption Value by Region (2025-2030) & (USD Million)
Table 127. South America Biodefense Consumption Value by Type (2019-2024) & (USD Million)
Table 128. South America Biodefense Consumption Value by Type (2025-2030) & (USD Million)
Table 129. South America Biodefense Consumption Value by Application (2019-2024) & (USD Million)
Table 130. South America Biodefense Consumption Value by Application (2025-2030) & (USD Million)
Table 131. South America Biodefense Consumption Value by Country (2019-2024) & (USD Million)
Table 132. South America Biodefense Consumption Value by Country (2025-2030) & (USD Million)
Table 133. Middle East & Africa Biodefense Consumption Value by Type (2019-2024) & (USD Million)
Table 134. Middle East & Africa Biodefense Consumption Value by Type (2025-2030) & (USD Million)
Table 135. Middle East & Africa Biodefense Consumption Value by Application (2019-2024) & (USD Million)
Table 136. Middle East & Africa Biodefense Consumption Value by Application (2025-2030) & (USD Million)
Table 137. Middle East & Africa Biodefense Consumption Value by Country (2019-2024) & (USD Million)
Table 138. Middle East & Africa Biodefense Consumption Value by Country (2025-2030) & (USD Million)
Table 139. Biodefense Raw Material
Table 140. Key Suppliers of Biodefense Raw Materials
Table 1. Global Biodefense Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Biodefense Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Biodefense Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Biodefense Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Emergent Biosolutions Company Information, Head Office, and Major Competitors
Table 6. Emergent Biosolutions Major Business
Table 7. Emergent Biosolutions Biodefense Product and Solutions
Table 8. Emergent Biosolutions Biodefense Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Emergent Biosolutions Recent Developments and Future Plans
Table 10. Hytest Company Information, Head Office, and Major Competitors
Table 11. Hytest Major Business
Table 12. Hytest Biodefense Product and Solutions
Table 13. Hytest Biodefense Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Hytest Recent Developments and Future Plans
Table 15. GSK Company Information, Head Office, and Major Competitors
Table 16. GSK Major Business
Table 17. GSK Biodefense Product and Solutions
Table 18. GSK Biodefense Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. GSK Recent Developments and Future Plans
Table 20. Sanofi Company Information, Head Office, and Major Competitors
Table 21. Sanofi Major Business
Table 22. Sanofi Biodefense Product and Solutions
Table 23. Sanofi Biodefense Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Sanofi Recent Developments and Future Plans
Table 25. PharmAthene Company Information, Head Office, and Major Competitors
Table 26. PharmAthene Major Business
Table 27. PharmAthene Biodefense Product and Solutions
Table 28. PharmAthene Biodefense Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. PharmAthene Recent Developments and Future Plans
Table 30. Bavarian Nordic Company Information, Head Office, and Major Competitors
Table 31. Bavarian Nordic Major Business
Table 32. Bavarian Nordic Biodefense Product and Solutions
Table 33. Bavarian Nordic Biodefense Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Bavarian Nordic Recent Developments and Future Plans
Table 35. SIGA Technologies Company Information, Head Office, and Major Competitors
Table 36. SIGA Technologies Major Business
Table 37. SIGA Technologies Biodefense Product and Solutions
Table 38. SIGA Technologies Biodefense Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. SIGA Technologies Recent Developments and Future Plans
Table 40. Arbutus Biopharma Company Information, Head Office, and Major Competitors
Table 41. Arbutus Biopharma Major Business
Table 42. Arbutus Biopharma Biodefense Product and Solutions
Table 43. Arbutus Biopharma Biodefense Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Arbutus Biopharma Recent Developments and Future Plans
Table 45. DynPort Vaccine Company Information, Head Office, and Major Competitors
Table 46. DynPort Vaccine Major Business
Table 47. DynPort Vaccine Biodefense Product and Solutions
Table 48. DynPort Vaccine Biodefense Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. DynPort Vaccine Recent Developments and Future Plans
Table 50. Xoma Corporation Company Information, Head Office, and Major Competitors
Table 51. Xoma Corporation Major Business
Table 52. Xoma Corporation Biodefense Product and Solutions
Table 53. Xoma Corporation Biodefense Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Xoma Corporation Recent Developments and Future Plans
Table 55. Ichor Medical Systems Company Information, Head Office, and Major Competitors
Table 56. Ichor Medical Systems Major Business
Table 57. Ichor Medical Systems Biodefense Product and Solutions
Table 58. Ichor Medical Systems Biodefense Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. Ichor Medical Systems Recent Developments and Future Plans
Table 60. Aeolus Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 61. Aeolus Pharmaceuticals Major Business
Table 62. Aeolus Pharmaceuticals Biodefense Product and Solutions
Table 63. Aeolus Pharmaceuticals Biodefense Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 64. Aeolus Pharmaceuticals Recent Developments and Future Plans
Table 65. Achaogen Company Information, Head Office, and Major Competitors
Table 66. Achaogen Major Business
Table 67. Achaogen Biodefense Product and Solutions
Table 68. Achaogen Biodefense Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 69. Achaogen Recent Developments and Future Plans
Table 70. Elusys Therapeutics Company Information, Head Office, and Major Competitors
Table 71. Elusys Therapeutics Major Business
Table 72. Elusys Therapeutics Biodefense Product and Solutions
Table 73. Elusys Therapeutics Biodefense Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 74. Elusys Therapeutics Recent Developments and Future Plans
Table 75. Dynavax Technologies Company Information, Head Office, and Major Competitors
Table 76. Dynavax Technologies Major Business
Table 77. Dynavax Technologies Biodefense Product and Solutions
Table 78. Dynavax Technologies Biodefense Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 79. Dynavax Technologies Recent Developments and Future Plans
Table 80. Cleveland BioLabs Company Information, Head Office, and Major Competitors
Table 81. Cleveland BioLabs Major Business
Table 82. Cleveland BioLabs Biodefense Product and Solutions
Table 83. Cleveland BioLabs Biodefense Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 84. Cleveland BioLabs Recent Developments and Future Plans
Table 85. Soligenix Company Information, Head Office, and Major Competitors
Table 86. Soligenix Major Business
Table 87. Soligenix Biodefense Product and Solutions
Table 88. Soligenix Biodefense Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. Soligenix Recent Developments and Future Plans
Table 90. Alnylam Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 91. Alnylam Pharmaceuticals Major Business
Table 92. Alnylam Pharmaceuticals Biodefense Product and Solutions
Table 93. Alnylam Pharmaceuticals Biodefense Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 94. Alnylam Pharmaceuticals Recent Developments and Future Plans
Table 95. Global Biodefense Revenue (USD Million) by Players (2019-2024)
Table 96. Global Biodefense Revenue Share by Players (2019-2024)
Table 97. Breakdown of Biodefense by Company Type (Tier 1, Tier 2, and Tier 3)
Table 98. Market Position of Players in Biodefense, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 99. Head Office of Key Biodefense Players
Table 100. Biodefense Market: Company Product Type Footprint
Table 101. Biodefense Market: Company Product Application Footprint
Table 102. Biodefense New Market Entrants and Barriers to Market Entry
Table 103. Biodefense Mergers, Acquisition, Agreements, and Collaborations
Table 104. Global Biodefense Consumption Value (USD Million) by Type (2019-2024)
Table 105. Global Biodefense Consumption Value Share by Type (2019-2024)
Table 106. Global Biodefense Consumption Value Forecast by Type (2025-2030)
Table 107. Global Biodefense Consumption Value by Application (2019-2024)
Table 108. Global Biodefense Consumption Value Forecast by Application (2025-2030)
Table 109. North America Biodefense Consumption Value by Type (2019-2024) & (USD Million)
Table 110. North America Biodefense Consumption Value by Type (2025-2030) & (USD Million)
Table 111. North America Biodefense Consumption Value by Application (2019-2024) & (USD Million)
Table 112. North America Biodefense Consumption Value by Application (2025-2030) & (USD Million)
Table 113. North America Biodefense Consumption Value by Country (2019-2024) & (USD Million)
Table 114. North America Biodefense Consumption Value by Country (2025-2030) & (USD Million)
Table 115. Europe Biodefense Consumption Value by Type (2019-2024) & (USD Million)
Table 116. Europe Biodefense Consumption Value by Type (2025-2030) & (USD Million)
Table 117. Europe Biodefense Consumption Value by Application (2019-2024) & (USD Million)
Table 118. Europe Biodefense Consumption Value by Application (2025-2030) & (USD Million)
Table 119. Europe Biodefense Consumption Value by Country (2019-2024) & (USD Million)
Table 120. Europe Biodefense Consumption Value by Country (2025-2030) & (USD Million)
Table 121. Asia-Pacific Biodefense Consumption Value by Type (2019-2024) & (USD Million)
Table 122. Asia-Pacific Biodefense Consumption Value by Type (2025-2030) & (USD Million)
Table 123. Asia-Pacific Biodefense Consumption Value by Application (2019-2024) & (USD Million)
Table 124. Asia-Pacific Biodefense Consumption Value by Application (2025-2030) & (USD Million)
Table 125. Asia-Pacific Biodefense Consumption Value by Region (2019-2024) & (USD Million)
Table 126. Asia-Pacific Biodefense Consumption Value by Region (2025-2030) & (USD Million)
Table 127. South America Biodefense Consumption Value by Type (2019-2024) & (USD Million)
Table 128. South America Biodefense Consumption Value by Type (2025-2030) & (USD Million)
Table 129. South America Biodefense Consumption Value by Application (2019-2024) & (USD Million)
Table 130. South America Biodefense Consumption Value by Application (2025-2030) & (USD Million)
Table 131. South America Biodefense Consumption Value by Country (2019-2024) & (USD Million)
Table 132. South America Biodefense Consumption Value by Country (2025-2030) & (USD Million)
Table 133. Middle East & Africa Biodefense Consumption Value by Type (2019-2024) & (USD Million)
Table 134. Middle East & Africa Biodefense Consumption Value by Type (2025-2030) & (USD Million)
Table 135. Middle East & Africa Biodefense Consumption Value by Application (2019-2024) & (USD Million)
Table 136. Middle East & Africa Biodefense Consumption Value by Application (2025-2030) & (USD Million)
Table 137. Middle East & Africa Biodefense Consumption Value by Country (2019-2024) & (USD Million)
Table 138. Middle East & Africa Biodefense Consumption Value by Country (2025-2030) & (USD Million)
Table 139. Biodefense Raw Material
Table 140. Key Suppliers of Biodefense Raw Materials
LIST OF FIGURES
Figure 1. Biodefense Picture
Figure 2. Global Biodefense Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Biodefense Consumption Value Market Share by Type in 2023
Figure 4. Anthrax
Figure 5. Smallpox
Figure 6. Botulism
Figure 7. Radiation/Nuclear
Figure 8. Others
Figure 9. Global Biodefense Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 10. Biodefense Consumption Value Market Share by Application in 2023
Figure 11. US Military Market Picture
Figure 12. US Civilian Market Picture
Figure 13. Non - US Market Picture
Figure 14. Global Biodefense Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 15. Global Biodefense Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 16. Global Market Biodefense Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 17. Global Biodefense Consumption Value Market Share by Region (2019-2030)
Figure 18. Global Biodefense Consumption Value Market Share by Region in 2023
Figure 19. North America Biodefense Consumption Value (2019-2030) & (USD Million)
Figure 20. Europe Biodefense Consumption Value (2019-2030) & (USD Million)
Figure 21. Asia-Pacific Biodefense Consumption Value (2019-2030) & (USD Million)
Figure 22. South America Biodefense Consumption Value (2019-2030) & (USD Million)
Figure 23. Middle East and Africa Biodefense Consumption Value (2019-2030) & (USD Million)
Figure 24. Global Biodefense Revenue Share by Players in 2023
Figure 25. Biodefense Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 26. Global Top 3 Players Biodefense Market Share in 2023
Figure 27. Global Top 6 Players Biodefense Market Share in 2023
Figure 28. Global Biodefense Consumption Value Share by Type (2019-2024)
Figure 29. Global Biodefense Market Share Forecast by Type (2025-2030)
Figure 30. Global Biodefense Consumption Value Share by Application (2019-2024)
Figure 31. Global Biodefense Market Share Forecast by Application (2025-2030)
Figure 32. North America Biodefense Consumption Value Market Share by Type (2019-2030)
Figure 33. North America Biodefense Consumption Value Market Share by Application (2019-2030)
Figure 34. North America Biodefense Consumption Value Market Share by Country (2019-2030)
Figure 35. United States Biodefense Consumption Value (2019-2030) & (USD Million)
Figure 36. Canada Biodefense Consumption Value (2019-2030) & (USD Million)
Figure 37. Mexico Biodefense Consumption Value (2019-2030) & (USD Million)
Figure 38. Europe Biodefense Consumption Value Market Share by Type (2019-2030)
Figure 39. Europe Biodefense Consumption Value Market Share by Application (2019-2030)
Figure 40. Europe Biodefense Consumption Value Market Share by Country (2019-2030)
Figure 41. Germany Biodefense Consumption Value (2019-2030) & (USD Million)
Figure 42. France Biodefense Consumption Value (2019-2030) & (USD Million)
Figure 43. United Kingdom Biodefense Consumption Value (2019-2030) & (USD Million)
Figure 44. Russia Biodefense Consumption Value (2019-2030) & (USD Million)
Figure 45. Italy Biodefense Consumption Value (2019-2030) & (USD Million)
Figure 46. Asia-Pacific Biodefense Consumption Value Market Share by Type (2019-2030)
Figure 47. Asia-Pacific Biodefense Consumption Value Market Share by Application (2019-2030)
Figure 48. Asia-Pacific Biodefense Consumption Value Market Share by Region (2019-2030)
Figure 49. China Biodefense Consumption Value (2019-2030) & (USD Million)
Figure 50. Japan Biodefense Consumption Value (2019-2030) & (USD Million)
Figure 51. South Korea Biodefense Consumption Value (2019-2030) & (USD Million)
Figure 52. India Biodefense Consumption Value (2019-2030) & (USD Million)
Figure 53. Southeast Asia Biodefense Consumption Value (2019-2030) & (USD Million)
Figure 54. Australia Biodefense Consumption Value (2019-2030) & (USD Million)
Figure 55. South America Biodefense Consumption Value Market Share by Type (2019-2030)
Figure 56. South America Biodefense Consumption Value Market Share by Application (2019-2030)
Figure 57. South America Biodefense Consumption Value Market Share by Country (2019-2030)
Figure 58. Brazil Biodefense Consumption Value (2019-2030) & (USD Million)
Figure 59. Argentina Biodefense Consumption Value (2019-2030) & (USD Million)
Figure 60. Middle East and Africa Biodefense Consumption Value Market Share by Type (2019-2030)
Figure 61. Middle East and Africa Biodefense Consumption Value Market Share by Application (2019-2030)
Figure 62. Middle East and Africa Biodefense Consumption Value Market Share by Country (2019-2030)
Figure 63. Turkey Biodefense Consumption Value (2019-2030) & (USD Million)
Figure 64. Saudi Arabia Biodefense Consumption Value (2019-2030) & (USD Million)
Figure 65. UAE Biodefense Consumption Value (2019-2030) & (USD Million)
Figure 66. Biodefense Market Drivers
Figure 67. Biodefense Market Restraints
Figure 68. Biodefense Market Trends
Figure 69. Porters Five Forces Analysis
Figure 70. Manufacturing Cost Structure Analysis of Biodefense in 2023
Figure 71. Manufacturing Process Analysis of Biodefense
Figure 72. Biodefense Industrial Chain
Figure 73. Methodology
Figure 74. Research Process and Data Source
Figure 1. Biodefense Picture
Figure 2. Global Biodefense Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Biodefense Consumption Value Market Share by Type in 2023
Figure 4. Anthrax
Figure 5. Smallpox
Figure 6. Botulism
Figure 7. Radiation/Nuclear
Figure 8. Others
Figure 9. Global Biodefense Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 10. Biodefense Consumption Value Market Share by Application in 2023
Figure 11. US Military Market Picture
Figure 12. US Civilian Market Picture
Figure 13. Non - US Market Picture
Figure 14. Global Biodefense Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 15. Global Biodefense Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 16. Global Market Biodefense Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 17. Global Biodefense Consumption Value Market Share by Region (2019-2030)
Figure 18. Global Biodefense Consumption Value Market Share by Region in 2023
Figure 19. North America Biodefense Consumption Value (2019-2030) & (USD Million)
Figure 20. Europe Biodefense Consumption Value (2019-2030) & (USD Million)
Figure 21. Asia-Pacific Biodefense Consumption Value (2019-2030) & (USD Million)
Figure 22. South America Biodefense Consumption Value (2019-2030) & (USD Million)
Figure 23. Middle East and Africa Biodefense Consumption Value (2019-2030) & (USD Million)
Figure 24. Global Biodefense Revenue Share by Players in 2023
Figure 25. Biodefense Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 26. Global Top 3 Players Biodefense Market Share in 2023
Figure 27. Global Top 6 Players Biodefense Market Share in 2023
Figure 28. Global Biodefense Consumption Value Share by Type (2019-2024)
Figure 29. Global Biodefense Market Share Forecast by Type (2025-2030)
Figure 30. Global Biodefense Consumption Value Share by Application (2019-2024)
Figure 31. Global Biodefense Market Share Forecast by Application (2025-2030)
Figure 32. North America Biodefense Consumption Value Market Share by Type (2019-2030)
Figure 33. North America Biodefense Consumption Value Market Share by Application (2019-2030)
Figure 34. North America Biodefense Consumption Value Market Share by Country (2019-2030)
Figure 35. United States Biodefense Consumption Value (2019-2030) & (USD Million)
Figure 36. Canada Biodefense Consumption Value (2019-2030) & (USD Million)
Figure 37. Mexico Biodefense Consumption Value (2019-2030) & (USD Million)
Figure 38. Europe Biodefense Consumption Value Market Share by Type (2019-2030)
Figure 39. Europe Biodefense Consumption Value Market Share by Application (2019-2030)
Figure 40. Europe Biodefense Consumption Value Market Share by Country (2019-2030)
Figure 41. Germany Biodefense Consumption Value (2019-2030) & (USD Million)
Figure 42. France Biodefense Consumption Value (2019-2030) & (USD Million)
Figure 43. United Kingdom Biodefense Consumption Value (2019-2030) & (USD Million)
Figure 44. Russia Biodefense Consumption Value (2019-2030) & (USD Million)
Figure 45. Italy Biodefense Consumption Value (2019-2030) & (USD Million)
Figure 46. Asia-Pacific Biodefense Consumption Value Market Share by Type (2019-2030)
Figure 47. Asia-Pacific Biodefense Consumption Value Market Share by Application (2019-2030)
Figure 48. Asia-Pacific Biodefense Consumption Value Market Share by Region (2019-2030)
Figure 49. China Biodefense Consumption Value (2019-2030) & (USD Million)
Figure 50. Japan Biodefense Consumption Value (2019-2030) & (USD Million)
Figure 51. South Korea Biodefense Consumption Value (2019-2030) & (USD Million)
Figure 52. India Biodefense Consumption Value (2019-2030) & (USD Million)
Figure 53. Southeast Asia Biodefense Consumption Value (2019-2030) & (USD Million)
Figure 54. Australia Biodefense Consumption Value (2019-2030) & (USD Million)
Figure 55. South America Biodefense Consumption Value Market Share by Type (2019-2030)
Figure 56. South America Biodefense Consumption Value Market Share by Application (2019-2030)
Figure 57. South America Biodefense Consumption Value Market Share by Country (2019-2030)
Figure 58. Brazil Biodefense Consumption Value (2019-2030) & (USD Million)
Figure 59. Argentina Biodefense Consumption Value (2019-2030) & (USD Million)
Figure 60. Middle East and Africa Biodefense Consumption Value Market Share by Type (2019-2030)
Figure 61. Middle East and Africa Biodefense Consumption Value Market Share by Application (2019-2030)
Figure 62. Middle East and Africa Biodefense Consumption Value Market Share by Country (2019-2030)
Figure 63. Turkey Biodefense Consumption Value (2019-2030) & (USD Million)
Figure 64. Saudi Arabia Biodefense Consumption Value (2019-2030) & (USD Million)
Figure 65. UAE Biodefense Consumption Value (2019-2030) & (USD Million)
Figure 66. Biodefense Market Drivers
Figure 67. Biodefense Market Restraints
Figure 68. Biodefense Market Trends
Figure 69. Porters Five Forces Analysis
Figure 70. Manufacturing Cost Structure Analysis of Biodefense in 2023
Figure 71. Manufacturing Process Analysis of Biodefense
Figure 72. Biodefense Industrial Chain
Figure 73. Methodology
Figure 74. Research Process and Data Source
